Opioid Use Treatment at Intervention Clinics Continues to Rise for Third Year
FRIDAY, Nov. 22, 2024 -- Opioid use disorder (OUD) treatment continued to increase in intervention clinics in the third year of implementation of the Massachusetts office-based addiction treatment (OBAT) model of nurse care management for OUD, according to a study published online Nov. 22 in JAMA Network Open.
Gwen T. Lapham, Ph.D., M.P.H., from the Kaiser Permanente Washington Health Research Institute in Seattle, and colleagues compared OUD medication treatment in intervention and usual care clinics over three years of implementation of the OBAT model of nurse care management for OUD in a preplanned secondary analysis of a cluster randomized implementation trial conducted in six health systems in five states. Eligible patients were aged 16 to 90 years visiting intervention or usual care clinics from three years before randomization to two years after.
Preintervention, 290,071 primary care patients were seen: 130,618 in intervention clinics and 159,453 in usual care clinics. The researchers found that intervention clinics provided 19.7 more patient-years of OUD treatment than usual care clinics per 10,000 primary care patients over three years postrandomization.
"Results suggest integration of a new model of OUD treatment into primary care takes time to overcome barriers and that implementation of the Massachusetts OBAT model leads to ongoing increases in OUD treatment among primary care patients in the third year of implementation," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
One in 10 Undergoing Early Cancer Surgery Have New Persistent Opioid Use
MONDAY, Sept. 8, 2025 -- More than one in 10 veterans undergoing surgery for early-stage cancer develop new persistent opioid use, according to a study published online Sept. 8 in...
Buprenorphine Available at 39.4 Percent of U.S. Pharmacies in 2023
WEDNESDAY, Sept. 3, 2025 -- From 2017 to 2023, there was an increase in buprenorphine availability overall, reaching 39.4 percent in 2023, according to a study published online...
59.0 Percent of Overdose Deaths Involved Stimulants in 2021 to 2024
TUESDAY, Sept. 2, 2025 -- From 2021 to 2024, 59.0 percent of overdose deaths involved stimulants, according to research published in the Aug. 28 issue of the U.S. Centers for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.